Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP322945.RAPdiWq5AFfNLDbmG-R_-1I8nk7gtJOikQH8QmPmeQC_Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP322945.RAPdiWq5AFfNLDbmG-R_-1I8nk7gtJOikQH8QmPmeQC_Q130_assertion type Assertion NP322945.RAPdiWq5AFfNLDbmG-R_-1I8nk7gtJOikQH8QmPmeQC_Q130_head.
- NP322945.RAPdiWq5AFfNLDbmG-R_-1I8nk7gtJOikQH8QmPmeQC_Q130_assertion description "[They also argue that combining PI3K/AKT/mTOR inhibitors with BH3 mimetics warrants attention in AML, particularly in the setting of basal AKT activation and/or addiction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP322945.RAPdiWq5AFfNLDbmG-R_-1I8nk7gtJOikQH8QmPmeQC_Q130_provenance.
- NP322945.RAPdiWq5AFfNLDbmG-R_-1I8nk7gtJOikQH8QmPmeQC_Q130_assertion evidence source_evidence_literature NP322945.RAPdiWq5AFfNLDbmG-R_-1I8nk7gtJOikQH8QmPmeQC_Q130_provenance.
- NP322945.RAPdiWq5AFfNLDbmG-R_-1I8nk7gtJOikQH8QmPmeQC_Q130_assertion SIO_000772 23243017 NP322945.RAPdiWq5AFfNLDbmG-R_-1I8nk7gtJOikQH8QmPmeQC_Q130_provenance.
- NP322945.RAPdiWq5AFfNLDbmG-R_-1I8nk7gtJOikQH8QmPmeQC_Q130_assertion wasDerivedFrom befree-20140225 NP322945.RAPdiWq5AFfNLDbmG-R_-1I8nk7gtJOikQH8QmPmeQC_Q130_provenance.
- NP322945.RAPdiWq5AFfNLDbmG-R_-1I8nk7gtJOikQH8QmPmeQC_Q130_assertion wasGeneratedBy ECO_0000203 NP322945.RAPdiWq5AFfNLDbmG-R_-1I8nk7gtJOikQH8QmPmeQC_Q130_provenance.